U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. VAXNEUVANCE
  1. Vaccines

VAXNEUVANCE

STN: 125741
Proper Name:  Pneumococcal 15-valent Conjugate Vaccine
Tradename: VAXNEUVANCE
Manufacturer:  Merck Sharp & Dohme LLC
Indication: Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older.

Product Information

Supporting Documents

 

Back to Top